TNF and rheumatoid arthritis: Moreover, in a small multicentre, open‐label, randomized clinical trial that compared anakinra with a host of TNF‐α blockers, IL‐1 inhibition with anakinra also proved effective in improving glycemic and inflammatory parameters in patients affected with rheumatoid arthritis and type 2 diabetes.100